Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anagrelide pharmacokinetics in young versus elderly patients with essential thrombocythaemia
2004-004058-20Phase 2Completed
- Sponsor
- Takeda
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of anagrelide in thrombocythemia (2 arms), sponsored by Takeda. Primary endpoint: Pharmacokinetic comparison of anagrelide and active metabolite. Started Apr 2006; status: completed.
02
Drugs
anagrelide
03
Conditions
thrombocythemia
Beyond the preview
Go deeper on 2004-004058-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004058-20.